William C. Mobley

Active 1974–2025

122
Papers
21,045
Citations
83
h-index
119
i10-index

Citations

Citations per year for William C. Mobley1974: 2 citations1975: 6 citations1976: 6 citations1977: 15 citations1978: 8 citations1979: 14 citations1980: 13 citations1981: 15 citations1982: 13 citations1983: 8 citations1984: 8 citations1985: 16 citations1986: 47 citations1987: 54 citations1988: 46 citations1989: 77 citations1990: 78 citations1991: 78 citations1992: 71 citations1993: 74 citations1994: 99 citations1995: 62 citations1996: 52 citations1997: 66 citations1998: 62 citations1999: 86 citations2000: 132 citations2001: 145 citations2002: 149 citations2003: 155 citations2004: 183 citations2005: 181 citations2006: 204 citations2007: 212 citations2008: 202 citations2009: 218 citations2010: 167 citations2011: 227 citations2012: 207 citations2013: 181 citations2014: 183 citations2015: 133 citations2016: 154 citations2017: 167 citations2018: 103 citations2019: 430 citations2020: 462 citations2021: 560 citations2022: 395 citations2023: 293 citations2024: 460 citations2025: 241 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,637 citing papers, 35.2% of this breakdownChina: 538 citing papers, 7.2% of this breakdownUnited Kingdom: 500 citing papers, 6.7% of this breakdownItaly: 405 citing papers, 5.4% of this breakdownGermany: 359 citing papers, 4.8% of this breakdownCanada: 298 citing papers, 4% of this breakdownSpain: 253 citing papers, 3.4% of this breakdownFrance: 251 citing papers, 3.3% of this breakdownJapan: 216 citing papers, 2.9% of this breakdownAustralia: 186 citing papers, 2.5% of this breakdownSwitzerland: 137 citing papers, 1.8% of this breakdownSweden: 135 citing papers, 1.8% of this breakdown
0%35.2%Other 21%

Fields

  • Medicine37.1%
  • Neuroscience28.8%
  • Biochemistry, Genetics and Molecular Biology26.3%
  • Agricultural and Biological Sciences1.6%
  • Engineering1.2%
  • Materials Science1%
  • Other4%

Topics

  • Nerve injury and regeneration6.9%
  • Alzheimer's disease research and treatments6.3%
  • Neurogenesis and neuroplasticity mechanisms4.1%
  • Down syndrome and intellectual disability research3.3%
  • Neuroscience and Neuropharmacology Research2.9%
  • Cellular transport and secretion2.7%
  • Other73.8%

Coauthors

All papers

Open in search
  1. Enabling Technologies for Personalized and Precision Medicine

    Authors: , , , , , , , , , , , , , , , - Trends in biotechnology 2020 cited by 484

  2. Reversing a model of Parkinson’s disease with in situ converted nigral neurons

    Authors: , , , , , , , , , , , , , , - Nature 2020 cited by 488

  3. Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species

    Authors: , - Frontiers in Neuroscience 2019 cited by 290

  4. Nerve Growth Factor Signaling, Neuroprotection, and Neural Repair

    Authors: , , - Annual Review of Neuroscience 2001 cited by 1,277

  5. Dementia in Down's syndrome

    Authors: , , , , - The Lancet Neurology 2016 cited by 263

  6. BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons

    Authors: , , , , , , , , - eLife 2023 cited by 98

  7. Down syndrome and Alzheimer's disease: Common pathways, common goals

    Authors: , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2014 cited by 302

  8. Further understanding the connection between Alzheimer's disease and Down syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2020 cited by 103

  9. Opportunities, barriers, and recommendations in Down syndrome research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernard Khor, Jeanne B. Lawrence, Catherine Lemonnier, Amy Feldman Lewanda, William C. Mobley, Paul E. Moore, Linda Nelson, Nicolas M. Oreskovic, Ricardo S. Osorio, David Patterson, Sonja A. Rasmussen, Roger H. Reeves, Nancy Roizen, Stephanie L. Santoro, Stephanie L. Sherman, Nasreen Talib, Ignacio E. Tapia, Kyle M. Walsh, Steven F. Warren, A. Nicole White, G. William Wong, John S. Yi - Translational Science of Rare Diseases 2021 cited by 99

  10. Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses

    Authors: , - Frontiers in Neuroscience 2019 cited by 178

  11. CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 64

  12. Widespread changes in dendritic and axonal morphology in Mecp2‐mutant mouse models of rett syndrome: Evidence for disruption of neuronal networks

    Authors: , , , , , , - The Journal of Comparative Neurology 2009 cited by 277

  13. Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2022 cited by 54

  14. Amyloid precursor protein–mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 184

  15. Preclinical validation of a potent γ-secretase modulator for Alzheimer’s disease prevention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2021 cited by 72

  16. Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model

    Authors: , , , , , , , , , , , - Alzheimer s & Dementia 2021 cited by 60

  17. Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Neuron 2010 cited by 254

  18. Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model

    Authors: , , , , , , , - Alzheimer s & Dementia 2020 cited by 54

  19. Disentangling self from pain: mindfulness meditation–induced pain relief is driven by thalamic–default mode network decoupling

    Authors: , , , , , - Pain 2022 cited by 41

  20. Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration

    Authors: , , , - Nature Aging 2024 cited by 28

  21. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2013 cited by 263

  22. The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome

    Authors: , , , , , , , - Genetics in Medicine 2009 cited by 261

  23. Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis

    Authors: , , , , , , , , , , , , , , , , , , - Neuron 2015 cited by 101

  24. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington’s disease

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 99